Gavin P. Robertson

Affiliations: 
Pennsylvania State University, State College, PA, United States 
Area:
Cell Biology, Oncology
Google:
"Gavin Robertson"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dinavahi SS, Chen YC, Punnath K, et al. (2022) Targeting WEE1/AKT restores p53-dependent NK cell activation to induce immune checkpoint blockade responses in 'cold' melanoma. Cancer Immunology Research
Dinavahi SS, Chen YC, Gowda R, et al. (2022) Targeting Protein Translation in Melanoma by Inhibiting EEF-2 Kinase Regulates Cholesterol Metabolism though SREBP2 to Inhibit Tumour Development. International Journal of Molecular Sciences. 23
Chen YC, Dinavahi SS, Feng Q, et al. (2021) Activating sphingosine-1-phospahte signaling in endothelial cells increases myosin light chain phosphorylation to decrease endothelial permeability thereby inhibiting cancer metastasis. Cancer Letters
Kardos GR, Gowda R, Dinavahi SS, et al. (2020) Salubrinal in Combination With 4E1RCat Synergistically Impairs Melanoma Development by Disrupting the Protein Synthetic Machinery. Frontiers in Oncology. 10: 834
Song C, Ge Z, Ding Y, et al. (2020) IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity inhigh-risk B-cell acute lymphoblastic leukemia. Blood
Gowda R, Robertson BM, Iyer S, et al. (2020) The role of exosomes in metastasis and progression of melanoma. Cancer Treatment Reviews. 85: 101975
Dinavahi SS, Gowda R, Bazewicz CG, et al. (2019) Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents. European Journal of Medicinal Chemistry. 187: 111962
Dinavahi SS, Gowda R, Gowda K, et al. (2019) Development of a novel multi-isoform ALDH inhibitor effective as an anti-melanoma agent. Molecular Cancer Therapeutics
Dinavahi SS, Bazewicz CG, Gowda R, et al. (2019) Aldehyde Dehydrogenase Inhibitors for Cancer Therapeutics. Trends in Pharmacological Sciences
Buj R, Chen CW, Dahl ES, et al. (2019) Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming. Cell Reports. 28: 1971-1980.e8
See more...